Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sagert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Hospital Pharmacy|October 1, 1994
Conformity with guidelines for antimicrobial prophylaxis against bacterial endocarditisG Sagert, T W Austin, A M Bombassaro, et al.
Plant Molecular Biology|July 5, 2001
A leucine-rich repeat region is conserved in pollen extensin-like (Pex) proteins in monocots and dicotsS Stratford, W Barne, D L Hohorst, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Hospital Pharmacy|October 1, 1994
Conformity with guidelines for antimicrobial prophylaxis against bacterial endocarditisG Sagert, T W Austin, A M Bombassaro, et al.
Plant Molecular Biology|July 5, 2001
A leucine-rich repeat region is conserved in pollen extensin-like (Pex) proteins in monocots and dicotsS Stratford, W Barne, D L Hohorst, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 1